Analysis: Investors likely to wait out 2012 drug launches
1/13/2012
SAN FRANCISCO - Burned by sorry early sales for new, grand biotech medicines in 2011, healthcare investors are cautious ahead of this year's expected crop of drug launches. Not so long ago, biotech makers could practic...
More: - Read More
Post Comment
Entry 1 of 16100
Last Page | Next Page









